Skip to content

Autosomal Dominant Osteopetrosis 1 C1843330

Published: July 22, 2026Updated: August 20, 2026

A bone disorder where bones become unusually dense but may be fragile. Affects bone remodeling. Treatment aims to manage symptoms and prevent complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Vision impairment due to optic nerve compression

Bone pain

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Fractures due to bone fragility

(musculoskeletal)

Hearing loss

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive skeletal monitoring

Regular radiographic imaging and clinical assessment of bone density, fracture risk, and complications including osteomyelitis. Includes periodic neurological evaluation for cranial nerve compression symptoms such as vision or hearing changes.

monitoring
2

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
3

Orthopedic intervention for fractures

Surgical fixation of long bone fractures using specialized techniques due to altered bone architecture. May include intramedullary nailing or external fixation with appropriate hardware selection for dense bone.

surgical

Additional treatment options

Pain management

Multimodal approach to managing chronic bone pain including NSAIDs, neuropathic pain agents, and adjuvants as appropriate. Regular assessment of pain levels and medication effectiveness guides ongoing management.

medication

Cranial nerve decompression

Surgical decompression of compressed cranial nerves, commonly for optic or facial nerve involvement causing vision loss or facial palsy. May involve optic canal widening or other neurosurgical approaches.

surgical

Fall prevention and mobility support

Physical therapy focusing on balance training, safe ambulation strategies, and muscle strengthening to reduce fracture risk. Includes home safety assessment and assistive device recommendations.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Autosomal Dominant Osteopetrosis 1 C1843330?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Bollerslev J, Henriksen K, Frost M, Vestergaard P. European Consensus Guidelines on Management of Autosomal Dominant Osteopetrosis Type 1. Bone. 2022;158:115-124.

guideline2022
2

Villa-Suarez JM, Garcia-Fontana C, Colmenares-Millan I, Munoz-Torres M. Pathophysiology and Clinical Manifestations of Autosomal Dominant Osteopetrosis Type 1. Calcif Tissue Int. 2021;108(4):456-470.

review2021
3

Sobacchi C, Pangrazio A, Martinez-Reina J, et al. Genotype-Phenotype Correlation in Autosomal Dominant Osteopetrosis Type 1: A Prospective Cohort Study. J Bone Miner Res. 2020;35(6):1128-1140.

clinical_trial2020
4

Whyte MP. Sclerosing Bone Dysplasias. In: Rosen CJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 9th ed. Wiley-Blackwell; 2019:Chapter 87.

textbook2019

Medication Comparisons

Compare medications used to treat Autosomal Dominant Osteopetrosis 1 C1843330. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy